174 related articles for article (PubMed ID: 24292435)
1. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
[TBL] [Abstract][Full Text] [Related]
2. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
Scheidweiler KB; Schwope DM; Karschner EL; Desrosiers NA; Gorelick DA; Huestis MA
Clin Chem; 2013 Jul; 59(7):1108-17. PubMed ID: 23519966
[TBL] [Abstract][Full Text] [Related]
3. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
[TBL] [Abstract][Full Text] [Related]
4. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
[TBL] [Abstract][Full Text] [Related]
5. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Schwope DM; Karschner EL; Gorelick DA; Huestis MA
Clin Chem; 2011 Oct; 57(10):1406-14. PubMed ID: 21836075
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.
Scheidweiler KB; Desrosiers NA; Huestis MA
Clin Chim Acta; 2012 Nov; 413(23-24):1839-47. PubMed ID: 22771478
[TBL] [Abstract][Full Text] [Related]
7. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
[TBL] [Abstract][Full Text] [Related]
8. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
Anizan S; Bergamaschi MM; Barnes AJ; Milman G; Desrosiers N; Lee D; Gorelick DA; Huestis MA
Drug Test Anal; 2015 Feb; 7(2):114-20. PubMed ID: 24995604
[TBL] [Abstract][Full Text] [Related]
9. An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.
Skopp G; Pötsch L
J Anal Toxicol; 2004; 28(1):35-40. PubMed ID: 14987422
[TBL] [Abstract][Full Text] [Related]
10. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
11. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid Stability in Postmortem Brain Samples Stored at Different Temperatures.
Santunione AL; Palazzoli F; Verri P; Vandelli D; Chiapelli F; Silingardi E
J Anal Toxicol; 2023 Mar; 47(2):121-128. PubMed ID: 35735137
[TBL] [Abstract][Full Text] [Related]
13. 11-nor-9-carboxy-Δ
Hanisch S; Paulke A; Toennes SW
J Pharm Biomed Anal; 2017 Nov; 146():261-265. PubMed ID: 28892757
[TBL] [Abstract][Full Text] [Related]
14. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
[TBL] [Abstract][Full Text] [Related]
15. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
[TBL] [Abstract][Full Text] [Related]
16. Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.
Scheidweiler KB; Andersson M; Swortwood MJ; Sempio C; Huestis MA
Drug Test Anal; 2017 Jan; 9(1):143-147. PubMed ID: 27539096
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.
Lee D; Milman G; Schwope DM; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Jul; 58(7):1101-9. PubMed ID: 22532594
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
[TBL] [Abstract][Full Text] [Related]
19. Investigation of a recently detected 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol isomer: Studies on the degradation of 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol glucuronide.
Hanisch S; Paulke A; Toennes SW
J Pharm Biomed Anal; 2016 Sep; 129():294-298. PubMed ID: 27448313
[TBL] [Abstract][Full Text] [Related]
20. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users.
Huestis MA; Blount BC; Milan DF; Newmeyer MN; Schroeder J; Smith ML
Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
